Congenital muscular dystrophy (CMD) is a heterogeneous group of disorders characterized by muscular hypotonia since birth and the histologic features of muscular dystrophy. Syndromic congenital muscular dystrophies are clinically similar autosomal recessive disorders characterized by congenital muscular dystrophy, lissencephaly, and eye anomalies.
INTRODUCTION
The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, characterized by congenital hypotonia, delayed motor development and early onset of progressive muscle weakness associated with a dystrophic pattern on muscle biopsy 1 . The genotype-phenotype correlations in syndromic muscular dystrophies with defective glycosylation of alphadystroglycans form a broad clinical spectrum 1, 2, 3 . Within this spectrum, Walker-Warburg syndrome (WWS), muscleeye-brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD) comprise the most severe conditions and are associated with varying degrees of defective brain migration and eye abnormalities 1, 2, 3 .
The diagnosis is established on the basis of four criteria: 1) congenital muscular dystrophy characterized by hypoglycosylation of α-dystroglycans; 2) high creatine kinase level; 3) anterior or posterior eye anomalies; and, 4) migration brain defect with type II lissencephaly.
The various types can be further distinguished with Immunohistochemistry and genetic testing. Among these, alpha-dystroglycanopathies, muscle-eye-brain disease is prevalent mainly in Finland 1,2,3,4 . We could not find any similar report from India.
CASE REPORT
An eight year old female presented with multiple joint contractures and motor predominant global developmental delay. She was born out of consanguineous marriage ( Figure. 1), at full term, via a normal delivery and had an uneventful perinatal period. She was apparently well till 5 months of age when parents noticed that the infant was "floppy". She attained head control at 18 months of age. She never sat or stood independently. At 3 years of age, she suffered febrile seizures and was prescribed antiepileptic medication for a period of 3 years. She started speaking 2-3 words at 3 years and full sentences at 5 years of age. Eventually she developed progressive muscle contractures involving the hip, knee and ankle joints bilaterally. In addition, she underwent bilateral cataract surgery at age of 6 years, as well as a brain MRI and muscle biopsy.
On clinical evaluation, she had right thoracolumbar scoliosis, bilateral 60 degrees flexion contractures of the hip joints, 90 degrees flexion deformity of the knee joints and equinus contracture at the ankles ( Figure 2 ) without any pseudohypertrophy of the calves. Regarding her upper limbs, there was 20 degrees of bilateral elbow flexion contracture and weakness of the small muscles of the hands bilaterally. Neurological examination revealed generalized hypotonia, nystagmus and diminished deep tendon reflexes. IQ evaluation showed moderate mental retardation. Based on the patient's history, clinical findings, elevated serum CPK, type II lissencephaly on brain MRI and dystrophic changes on muscle biopsy, a diagnosis of muscleeye-brain disease was made. The family was advised that she should undergo further molecular testing to identify the genetic defect which is necessary for prenatal diagnosis in future siblings; however, this was not accomplished due to financial constraints. Physicians explained to the family there is a 25% risk of recurrence in siblings.
DISCUSSION
Congenital muscular dystrophies (CMD) are a heterogeneous group of disorders characterized by congenital muscular hypotonia and the histologic features of muscular dystrophy. Based on the clinical, immunohistochemical, and genetic findings, different forms have been characterized. Syndromic CMDs include muscleeye-brain disease (MEB), Walker-Warburg syndrome(WWS) and Fukuyama congenital muscular dystrophy(FCMD) all due to genetic defects in glycosyltransferases as mentioned in Table I 1,2 . There is failure of glycosylation of alpha-dystroglycans, which are transmembrane glycoproteins in the sarcolemma of skeletal muscles, eyes and brain tissue 2, 3, 5 . This leads to failure of ligand binding, intercellular interactions and hence dystrophic changes in these tissues (Figure 3a and 3b) . Though these syndromic congenital muscular dystrophies have overlapping clinical features, there remain certain subtle differences 1, 2 , which help to distinguish among these various types of CMDs (Table II) . T Treatment is primarily supportive including: physical therapy and stretching exercises to promote mobility and prevent contractures or prevent them from worsening; use of mechanical assistive devices to help ambulation and mobility; and, correction of deformities based on the ambulatory capacity of the child. Genetic counselling should be offered to parents of such patients including avoidance of consanguineous marriage in the family since there is a twenty-five percent chance of each sibling of a proband to be affected. Utilization of prenatal testing in future siblings is also helpful.
No previous case report on muscle -eye-brain disease in India was found in the literature except for one case of another distinct variety of congenital muscular dystrophy (Fukuyama congenital muscular dystrophy) 5 . We speculate that muscle-eye-brain disease may be more common in India. It is imperative to consider this condition as a potential differential diagnosis when a child presents with persistent hypotonia or as a floppy baby. We suggest that registration of all neuromuscular disorders should be initiated in India so we may accurately calculate the prevalence of this condition and also work to prevent as well as rectify this crippling disorder in subsequent generations.
